HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing He Selected Research

stichoposide

1/2022Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing He Research Topics

Disease

154Neoplasms (Cancer)
06/2022 - 12/2004
36Inflammation (Inflammations)
05/2022 - 09/2005
28Infections
10/2022 - 03/2006
27Carcinogenesis
01/2022 - 08/2003
25Breast Neoplasms (Breast Cancer)
01/2022 - 04/2002
21Neuroblastoma
06/2022 - 12/2011
19Neoplasm Metastasis (Metastasis)
01/2022 - 04/2005
18Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 08/2011
18Acute Lung Injury
10/2021 - 01/2012
15Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 04/2004
14Rheumatoid Arthritis
11/2022 - 06/2008
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2020 - 03/2014
13Pre-Eclampsia (Preeclampsia)
11/2021 - 01/2005
13Insulin Resistance
01/2021 - 10/2002
12Leukemia
10/2022 - 10/2005
12Pulmonary Hypertension
01/2022 - 01/2014
12Stomach Neoplasms (Stomach Cancer)
01/2022 - 07/2012
12Pulmonary Arterial Hypertension
12/2020 - 02/2010
10Wilms Tumor (Wilm's Tumor)
01/2022 - 08/2017
10Hepatocellular Carcinoma (Hepatoma)
01/2021 - 08/2003
9Obesity
01/2022 - 10/2002
9Lung Injury
01/2022 - 01/2012
9Ischemia
01/2022 - 06/2008
9Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 08/2010
9Heart Failure
04/2018 - 02/2010
8Autoimmune Diseases (Autoimmune Disease)
10/2022 - 10/2013
8Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 11/2009
8Pulmonary Edema
01/2022 - 11/2012
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2002
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2022 - 01/2006
7Hepatoblastoma
01/2022 - 01/2021
7Thalassemia
12/2021 - 09/2011
7COVID-19
12/2021 - 01/2020
7Gestational Diabetes (Gestational Diabetes Mellitus)
11/2021 - 11/2009
7Edema (Dropsy)
02/2021 - 02/2012
7Type 2 Diabetes Mellitus (MODY)
01/2021 - 10/2002
7Carcinoma (Carcinomatosis)
12/2018 - 04/2002
6Esophageal Squamous Cell Carcinoma
06/2022 - 01/2012
6Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 08/2012
6Exanthema (Rash)
05/2022 - 10/2012
6Hypertension (High Blood Pressure)
01/2022 - 01/2014
6Familial Primary Pulmonary Hypertension
01/2022 - 08/2011
6Lupus Nephritis
12/2021 - 07/2012
6Fibrosis (Cirrhosis)
12/2021 - 09/2005
6Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2020 - 03/2013
6Pneumonia (Pneumonitis)
01/2018 - 12/2011
6Body Weight (Weight, Body)
01/2009 - 06/2003
5Hyperglycemia
01/2022 - 07/2004
5Arthritis (Polyarthritis)
01/2022 - 11/2008
5Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2022 - 11/2017
5Parkinson Disease (Parkinson's Disease)
01/2022 - 10/2016
5Necrosis
02/2021 - 01/2008
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2012
5Human Influenza (Influenza)
01/2021 - 12/2011

Drug/Important Bio-Agent (IBA)

71Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2002
31Biomarkers (Surrogate Marker)IBA
06/2022 - 09/2005
25ORALIT (ORS)IBA
01/2022 - 07/2006
21Biological ProductsIBA
06/2022 - 08/2003
20Messenger RNA (mRNA)IBA
01/2022 - 11/2004
18Pharmaceutical PreparationsIBA
10/2022 - 04/2002
18MicroRNAs (MicroRNA)IBA
06/2022 - 01/2013
18Therapeutic UsesIBA
05/2022 - 11/2007
17DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2004
17Long Noncoding RNAIBA
01/2022 - 01/2015
16Interleukin-2 (IL2)IBA
05/2022 - 08/2005
15CytokinesIBA
05/2022 - 08/2005
13LipopolysaccharidesIBA
01/2022 - 11/2010
13Insulin (Novolin)FDA Link
11/2021 - 06/2003
11Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2004
106-methyladenineIBA
01/2022 - 11/2018
10N-methyladenosineIBA
01/2022 - 01/2020
10RNA (Ribonucleic Acid)IBA
01/2022 - 09/2010
10EnzymesIBA
01/2022 - 11/2004
10AntibodiesIBA
10/2020 - 06/2008
9Peptides (Polypeptides)IBA
04/2022 - 11/2008
9Epithelial Sodium ChannelsIBA
01/2022 - 11/2012
8AutoantibodiesIBA
11/2022 - 08/2011
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2020 - 08/2005
8Transcription Factors (Transcription Factor)IBA
03/2020 - 11/2006
7MethyltransferasesIBA
01/2022 - 11/2018
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2007
7CollagenIBA
01/2021 - 12/2008
7deguelinIBA
01/2017 - 07/2005
7Mitochondrial DNA (mtDNA)IBA
01/2016 - 07/2010
6Hormones (Hormone)IBA
01/2022 - 12/2004
6Oxygen (Dioxygen)IBA
01/2022 - 10/2009
6ErbB Receptors (EGF Receptor)IBA
01/2022 - 11/2013
6Indicators and Reagents (Reagents)IBA
01/2021 - 11/2005
6LipidsIBA
01/2021 - 10/2002
6Immunoglobulin G (IgG)IBA
10/2020 - 01/2011
6Interleukin-6 (Interleukin 6)IBA
12/2018 - 10/2006
6Immunoglobulins (Immunoglobulin)IBA
12/2018 - 07/2015
5Blood Glucose (Blood Sugar)IBA
11/2021 - 01/2018
5Bevacizumab (Avastin)FDA Link
02/2021 - 10/2011

Therapy/Procedure

74Therapeutics
06/2022 - 06/2003
21Drug Therapy (Chemotherapy)
02/2022 - 04/2002
8Transplantation
05/2022 - 02/2009
6Cesarean Section (Caesarean Section)
01/2022 - 09/2010
5Acupuncture Therapy
01/2022 - 09/2005
5Moxibustion
01/2022 - 02/2005